There are still some kinks to be ironed out, including risks of hemolysis and valve thrombosis, to put things on par with ...
Erlanger Health announces the recent completion of surgeries using new Pulsed Field Ablation (PFA) technology to better treat patients battling atrial fibrillation (AFib). Officials said, "As the ...
EMPAVELI's key market opportunities include its strong differentiation through C3 inhibition, capturing PNH patients inadequately controlled by C5 inhibitors. Expansion into rare kidney diseases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results